title: Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures.
abstract: Tissue infiltration of macrophages, although critical for innate immunity, is also involved in pathologies, such as chronic inflammation and cancer. In vivo, macrophages migrate mostly in a constrained three-dimensional (3D) environment. However, in vitro studies, mainly focused on two dimensions, do not provide meaningful clues about the mechanisms involved in 3D macrophage migration. In contrast, tumor cell 3D migration is well documented. It comprises a protease-independent and Rho kinase (ROCK)-dependent amoeboid migration mode and a protease-dependent and ROCK-independent mesenchymal migration mode. In this study, we examined the influence of extracellular matrix (composition, architecture, and stiffness) on 3D migration of human macrophages derived from blood monocytes (MDMs). We show that: 1) MDMs use either the amoeboid migration mode in fibrillar collagen I or the mesenchymal migration mode in Matrigel and gelled collagen I, whereas HT1080 tumor cells only perform mesenchymal migration; 2) when MDMs use the mesenchymal migratory mode, they form 3D collagenolytic structures at the tips of cell protrusions that share several markers with podosomes as described in two dimensions; 3) in contrast to tumor cells, matrix metalloproteinase inhibitors do not impair protease-dependent macrophage 3D migration, suggesting the involvement of other proteolytic systems; and 4) MDMs infiltrating matrices of similar composition but with variable stiffness adapt their migration mode primarily to the matrix architecture. In conclusion, although it is admitted that leukocytes 3D migration is restricted to the amoeboid mode, we show that human macrophages also perform the mesenchymal mode but in a distinct manner than tumor cells, and they naturally adapt their migration mode to the environmental constraints.
authors.affiliation: Centre National de la Recherche Scientifique, Université de Toulouse, Toulouse, France.
authors.forename: Emeline
authors.initials: E
authors.lastname: Van Goethem
authors.forename: Renaud
authors.initials: R
authors.lastname: Poincloux
authors.forename: Fabienne
authors.initials: F
authors.lastname: Gauffre
authors.forename: Isabelle
authors.initials: I
authors.lastname: Maridonneau-Parini
authors.forename: Véronique
authors.initials: V
authors.lastname: Le Cabec
mesh_terms: D000656:Amoeba; D002465:Cell Movement / Q000187:drug effects; D022081:Cell Surface Extensions / Q000502:physiology*; D002478:Cells, Cultured; D003094:Collagen / Q000494:pharmacology; D024042:Collagen Type I / Q000494:pharmacology; D004338:Drug Combinations; D005109:Extracellular Matrix / Q000502:physiology*; D006801:Humans; D007797:Laminin / Q000494:pharmacology; D008264:Macrophages / Q000166:cytology* / Q000648:ultrastructure; D059630:Mesenchymal Stem Cells; D009000:Monocytes; D010447:Peptide Hydrolases; D011509:Proteoglycans / Q000494:pharmacology
chemical_list: D024042:Collagen Type I; D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D003094:Collagen; D010447:Peptide Hydrolases